MedTrace Logo

Pregnant and Lactating Individuals & Newborns COVID-19 Vaccination Prospective Cohort Study

NCT05115617 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-03-07

No results posted yet for this study

Summary

The PLAN-V Study is an Ontario-based prospective, longitudinal study that will consist of extensive biosampling and detailed data collection from pregnant women/individuals, who have received the COVID-19 vaccine during their pregnancy, and their infants across the antenatal, delivery and postpartum periods.

Conditions

  • SARS-CoV2 Infection
  • Covid19
  • Vaccine Reaction
  • Pregnancy Related
  • Immunogenicity

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Children's Hospital of Eastern Ontario Research Institute

    collaborator OTHER

  • University of Ottawa

    collaborator OTHER

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Darine El-Chaâr, MD, MSc · The Ottawa Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-03
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05115617 on ClinicalTrials.gov